|
US4275149A
(en)
|
1978-11-24 |
1981-06-23 |
Syva Company |
Macromolecular environment control in specific receptor assays
|
|
US4318980A
(en)
|
1978-04-10 |
1982-03-09 |
Miles Laboratories, Inc. |
Heterogenous specific binding assay employing a cycling reactant as label
|
|
US4424200A
(en)
|
1979-05-14 |
1984-01-03 |
Nuc Med Inc. |
Method for radiolabeling proteins with technetium-99m
|
|
US4479930A
(en)
|
1982-07-26 |
1984-10-30 |
Trustees Of The University Of Massachusetts |
Amines coupled wth dicyclic dianhydrides capable of being radiolabeled product
|
|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
JPS61134325A
(ja)
|
1984-12-04 |
1986-06-21 |
Teijin Ltd |
ハイブリツド抗体遺伝子の発現方法
|
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
|
US4987071A
(en)
|
1986-12-03 |
1991-01-22 |
University Patents, Inc. |
RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
|
|
US5185243A
(en)
|
1988-08-25 |
1993-02-09 |
Syntex (U.S.A.) Inc. |
Method for detection of specific nucleic acid sequences
|
|
GB8928874D0
(en)
|
1989-12-21 |
1990-02-28 |
Celltech Ltd |
Humanised antibodies
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
ATE207080T1
(de)
|
1991-11-25 |
2001-11-15 |
Enzon Inc |
Multivalente antigen-bindende proteine
|
|
ES2156149T3
(es)
|
1992-12-04 |
2001-06-16 |
Medical Res Council |
Proteinas de union multivalente y multiespecificas, su fabricacion y su uso.
|
|
US6121022A
(en)
|
1995-04-14 |
2000-09-19 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
|
GB9509957D0
(en)
|
1995-05-17 |
1995-07-12 |
Khalil Nasreen |
Post-translational activation of tgf-1 involving the tsp-1 receptor cd36
|
|
US5814468A
(en)
|
1996-03-27 |
1998-09-29 |
Coulter International Corp. |
Methods of enumerating receptor molecules for specific binding partners on formed bodies and in solution
|
|
US5958671A
(en)
|
1996-04-23 |
1999-09-28 |
Presidents And Fellows Of Harvard College |
Methods and compositions for regulating T cell subsets by modulating transcription factor activity
|
|
DE69740107D1
(de)
|
1996-12-23 |
2011-03-10 |
Immunex Corp |
Rezeptor aktivator von nf-kappa b, rezeptor is mitglied der tnf rezeptor superfamilie
|
|
US6316408B1
(en)
|
1997-04-16 |
2001-11-13 |
Amgen Inc. |
Methods of use for osetoprotegerin binding protein receptors
|
|
US6274338B1
(en)
*
|
1998-02-24 |
2001-08-14 |
President And Fellows Of Harvard College |
Human c-Maf compositions and methods of use thereof
|
|
DK1137941T4
(da)
|
1998-12-10 |
2014-01-06 |
Brystol Myers Squibb Company |
Protein-scaffolds til antistof-mimetika og andre bindingsproteiner
|
|
DE60021254T2
(de)
|
1999-03-15 |
2006-04-20 |
AXYS Pharmaceuticals, Inc., South San Francisco |
N-cyanomethylamide als protease inhibitoren
|
|
DE60132975T2
(de)
|
2000-01-06 |
2009-02-26 |
Merck Frosst Canada Inc., Kirkland |
Neue substanzen und verbindungen als protease-inhibitoren
|
|
EP1272668B1
(en)
|
2000-04-03 |
2007-02-14 |
Corixa Corporation |
Methods, compositions and kits for the detection and monitoring of breast cancer
|
|
US7700359B2
(en)
|
2000-06-02 |
2010-04-20 |
Novartis Vaccines And Diagnostics, Inc. |
Gene products differentially expressed in cancerous cells
|
|
EP2295081B1
(en)
|
2001-06-26 |
2018-10-31 |
Amgen Inc. |
Antibodies to OPGL
|
|
MXPA05000511A
(es)
|
2001-07-12 |
2005-09-30 |
Jefferson Foote |
Anticuepros super humanizados.
|
|
AR036375A1
(es)
|
2001-08-30 |
2004-09-01 |
Novartis Ag |
Compuestos pirrolo [2,3-d] pirimidina -2- carbonitrilo, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos compuestos para la preparacion de medicamentos
|
|
GB0121033D0
(en)
|
2001-08-30 |
2001-10-24 |
Novartis Ag |
Organic compounds
|
|
JP4238138B2
(ja)
|
2001-12-22 |
2009-03-11 |
４−アンチボディ アーゲー |
遺伝的に修飾された脊椎動物前駆体リンパ球の生成方法及び異種結合タンパク質の産生を目的としたその使用。
|
|
SE0201980D0
(sv)
|
2002-06-24 |
2002-06-24 |
Astrazeneca Ab |
Novel compounds
|
|
WO2005046731A1
(en)
|
2003-10-17 |
2005-05-26 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Interference with c-maf function in multiple myeloma
|
|
WO2005060722A2
(en)
|
2003-12-18 |
2005-07-07 |
President And Fellows Of Hardvard College |
Modulation of immune system function by modulation of polypeptide arginine methyltransferases
|
|
US9134237B2
(en)
|
2005-09-20 |
2015-09-15 |
Janssen Diagnotics, LLC |
High sensitivity multiparameter method for rare event analysis in a biological sample
|
|
CA2623405C
(en)
|
2005-09-20 |
2014-11-25 |
Immunivest Corporation |
Methods and composition to generate unique sequence dna probes labeling of dna probes and the use of these probes
|
|
EP1777523A1
(en)
|
2005-10-19 |
2007-04-25 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method
|
|
EP2046971B1
(en)
|
2006-06-30 |
2012-04-04 |
University Of Southern California |
Quantifiable internal reference standards for immunohistochemistry and uses thereof
|
|
WO2008086800A2
(en)
|
2007-01-15 |
2008-07-24 |
Aarhus Universitet |
Predisposition to, prognosis for and treatment of breast cancer relating to human chromosome 16
|
|
WO2008098351A1
(en)
|
2007-02-14 |
2008-08-21 |
University Health Network |
Treatment of d-cyclin mediated proliferative diseases and hemotological malignancies
|
|
CA2676791A1
(en)
|
2007-02-16 |
2008-11-06 |
Pacific Arrow Limited |
Blocking the migration or metastasis of cancer cells by affecting adhesion proteins and the uses of new compounds thereof
|
|
CA2687903C
(en)
|
2007-05-24 |
2016-09-13 |
Ablynx N.V. |
Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders
|
|
WO2010003773A1
(en)
|
2008-06-16 |
2010-01-14 |
Siemens Medical Solutions Diagnostics Gmbh |
Algorithms for outcome prediction in patients with node-positive chemotherapy-treated breast cancer
|
|
WO2010110346A1
(ja)
|
2009-03-24 |
2010-09-30 |
独立行政法人理化学研究所 |
白血病幹細胞マーカー
|
|
WO2011039734A2
(en)
|
2009-10-02 |
2011-04-07 |
Enzo Medico |
Use of genes involved in anchorage independence for the optimization of diagnosis and treatment of human cancer
|
|
EP3517630B1
(en)
|
2010-10-06 |
2022-01-19 |
Institució Catalana de Recerca i Estudis Avançats |
Method for the diagnosis, prognosis and treatment of breast cancer metastasis
|
|
US20140162887A1
(en)
|
2011-02-04 |
2014-06-12 |
Bioarray Therapeutics, Inc. |
Methods of using gene expression signatures to select a method of treatment, predict prognosis, survival, and/or predict response to treatment
|
|
EP2650682A1
(en)
*
|
2012-04-09 |
2013-10-16 |
Fundació Privada Institut de Recerca Biomèdica |
Method for the prognosis and treatment of cancer metastasis
|
|
EP3467124A1
(en)
*
|
2012-06-06 |
2019-04-10 |
Fundació Institut de Recerca Biomèdica IRB (Barcelona) |
Method for the diagnosis, prognosis and treatment of lung cancer metastasis
|
|
US10119171B2
(en)
|
2012-10-12 |
2018-11-06 |
Inbiomotion S.L. |
Method for the diagnosis, prognosis and treatment of prostate cancer metastasis
|
|
KR101872965B1
(ko)
|
2012-10-12 |
2018-06-29 |
인바이오모션 에스.엘. |
Ｃ―ｍａｆ를 이용하는 전립선암 전이의 진단, 예후 및 치료 방법
|
|
CA2903306A1
(en)
|
2013-03-15 |
2014-09-18 |
Fundacio Institut De Recerca Biomedica (Irb Barcelona) |
Method for the diagnosis, prognosis and treatment of metastatic cancer
|
|
WO2014184679A2
(en)
|
2013-03-15 |
2014-11-20 |
Inbiomotion S.L. |
Method for the prognosis and treatment of renal cell carcinoma metastasis
|
|
JP6577873B2
(ja)
|
2013-03-15 |
2019-09-18 |
フンダシオ、インスティトゥト、デ、レセルカ、ビオメディカ（イエレベ、バルセロナ）Ｆｕｎｄａｃｉｏ Ｉｎｓｔｉｔｕｔ Ｄｅ Ｒｅｃｅｒｃａ Ｂｉｏｍｅｄｉｃａ （Ｉｒｂ Ｂａｒｃｅｌｏｎａ） |
がんの転移の予後診断および処置のための方法
|
|
TR201907389T4
(tr)
|
2013-10-09 |
2019-06-21 |
Fundacio Inst De Recerca Biomedica Irb Barcelona |
Meme kanserinden kaynaklanan metastazlı kemik kanserinin prognozu ve tedavisine yönelik yöntem.
|
|
KR20170093182A
(ko)
|
2014-12-11 |
2017-08-14 |
인바이오모션 에스.엘. |
인간 c-maf에 대한 결합 구성원
|
|
AU2017271385B2
(en)
|
2016-05-25 |
2023-10-05 |
Inbiomotion S.L. |
Therapeutic treatment of breast cancer based on c-MAF status
|
|
MX2020005182A
(es)
|
2017-11-22 |
2020-08-17 |
Inbiomotion Sl |
Tratamiento terapeutico del cancer de mama basado en el estado del c-maf.
|